Have a personal or library account? Click to login
Systemic Treatment of Ewing Sarcoma: Current Options and Future Perspectives Cover

Systemic Treatment of Ewing Sarcoma: Current Options and Future Perspectives

Forum of Clinical Oncology
Volume 12 (2021): Issue 3 (December 2021)
By: Jose Duran Moreno,  Georgios Papageorgiou,  Ioanna Gazouli and  Anastasios Kyriazoglou  
Open Access
|Feb 2022

Authors

Jose Duran Moreno

PPD Pharmaceuticals, Athens, Greece

Georgios Papageorgiou

Division of Medical Oncology & Hematopoietic Cell Transplant Unit, Department of Medicine, Metaxa Cancer Hospital, Piraeus, Greece

Ioanna Gazouli

University Hospital of Ioannina, Department of Medical Oncology

Anastasios Kyriazoglou

tassoskyr@gmail.com

Attikon University Hospital, Second Propaedeutic Department of Medicine, Athens, Greece
Attikon University Hospital, Second Propaedeutic Department of Medicine, Athens, Greece
DOI: https://doi.org/10.2478/fco-2021-0005 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 3 - 27
Submitted on: Jul 13, 2020
|
Accepted on: Jan 9, 2021
|
Published on: Feb 1, 2022
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Ewing sarcoma,
chemotherapy,
systemic treatment
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2022 Jose Duran Moreno, Georgios Papageorgiou, Ioanna Gazouli, Anastasios Kyriazoglou, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 12 (2021): Issue 3 (December 2021)Next article